Acute osteomyelitis of the humerus mimicking malignancy: Streptococcus pneumoniaeas exceptional pathogen in an immunocompetent adult by Peter M Prodinger et al.
CASE REPORT Open Access
Acute osteomyelitis of the humerus mimicking
malignancy: Streptococcus pneumoniae as
exceptional pathogen in an immunocompetent
adult
Peter M Prodinger1*, Hakan Pilge2, Ingo J Banke1, Dominik Bürklein3, Reiner Gradinger1, Thomas Miethke4
and Boris M Holzapfel3*
Abstract
Background: Chronic osteomyelitis due to direct bone trauma or vascular insufficiency is a frequent problem in
orthopaedic surgery. In contrast, acute haematogenous osteomyelitis represents a rare entity that almost exclusively
affects prepubescent children or immunodeficient adults.
Case Presentation: In this article, we report the case of acute pneumococcal osteomyelitis of the humerus in an
immunocompetent and otherwise healthy 44-year-old male patient presenting with minor inflammation signs and
misleading clinical features.
Conclusions: The diagnosis had to be confirmed by open biopsy which allowed the initiation of a targeted
therapy. A case of pneumococcal osteomyelitis of a long bone, lacking predisposing factors or trauma, is unique in
adults and has not been reported previously.
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Background
S. pneumoniae, or pneumococcus, is a Gram-positive,
alpha-haemolytic and bile soluble diplococcus. This
bacteria is facultative anaerobe and a member of the
genus Streptococcus. S. pneumonia, it’s the most com-
mon cause of bacterial meningitis in adults and chil-
dren, and is one of the top two isolates found in otitis
media [1]. Bacteremia rarely leads to pneumococcal
osteomyelitis or septic arthritis in premature infants
and neonates [2] or in immunodeficient adults [3]. S.
pneumoniae has never been associated to acute osteo-
myelitis in immunocompetent patients so far.
In the following we present the case of acute osteomye-
litis caused by pneumococci in a healthy adult patient.
Due to the nonspecific nature of the clinical and radio-
logical features presented, diagnosis had to be secured by
open biopsy. This enabled us to initiate targeted antibiotic
treatment. In this article we furthermore review the recent
literature and discuss actual therapeutic strategies for
acute, haematogenous osteomyelitis.
Case presentation
A 44-year-old otherwise healthy male was referred to the
orthopaedic unit with a four week history of minor pain in
the right upper arm. The onset of pain was accompanied
by an episode of flu-like symptoms that subsided immedi-
ately. Later, an indolent swelling was noted on the lateral
side of the upper arm. Increasing numbness in the lateral
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The physical examination indicated a palpable, indolent
soft tissue tumour located at the dorso-lateral, distal side
of the right humerus. The localisation of the numb area
reported by the patient corresponded to area of the radial
nerve´s sensible innervation. A blood sample was taken
and revealed mild anaemia (Hb 13,0 mg/dl [norm: 14–
18 mg/dl]), moderate leucocytosis (11,46 G/l [norm:
4,0–9,0 G/l]) and slightly elevated CRP (1,8 mg/dl
[norm: <0,5 mg/dl]) and CK (232 U/l [norm: <174 U/l]).
Subsequently, X-rays of the right humerus showed cor-
tical disaggregation and extraosseal soft tissue swelling
(Figure 1) and were highly indicative for malignancy.
MRI of the right upper arm revealed an inhomogenous
tumour affecting the dia- and metaphysis of the right hu-
merus (normal marrow displaced, T1 and T2 hyperintense
noduli). The corticalis was infiltrated and permeated, lead-
ing to a small extraosseal tumour mass (15 × 6 mm) on
the dorsolateral side of the bone. This tumour mass led to
a compression of the radial nerve (Figure 2).
Therefore, an open biopsy of the proximal diaphysis of
the right humerus was performed. After drilling into the
bone, spontaneous extrusion of purulence was evident.
Microbiological samples were takenand the marrow
space rinsed and drained (Figure 3). Calculated antibiotic
treatment with Cefuroxim (4,5 g/d i.v.) was initiated
and switched to Ceftriaxone (2 g/d i.v.) after Streptococcus
pneumoniae was identified. Screening for infections cau-
sing immunodeficiency (HIV, Hep. B, Hep. C, EBV, CMV,
Mycobacteria) was negative. Congenital asplenia was ruled
out by a routine ultrasound check-up. A pharyngeal swab
did not show local colonisation with S. pneumoniae and
pathologies of the lungs including clinical unapparent
pneumonia were excluded by chest X-ray.
The patient was discharged on the 10th postoperative
day showing no signs of infection. Antimicrobiotic treat-
ment was changed to Cefuroxim 1000 mg/d p.o. and con-
tinued for four weeks. Following check-ups after 30 days,
3 months and 9 months did not result in any pathological
finding. Clinically, the scar tissue showed no signs of
persistent infection, the patient did not report any pain in
the shoulder or arm and the function of the limb was nor-
mal. The white blood cell count was normal at discharge
and stayed normal during the whole follow up. CRP
at discharge was slightly elevated (1,1 mg/dl [norm:
<0,5 mg/dl]), at 30 days it decreased to 0,3 mg/dl and
stayed below 0,5 mg/dl thereafter. We performed X-rays
of the humerus after 30 days and a control MRI-scan
after 3 months. Both revealed no signs of osteonecrosis
complicating the infection.
Acute osteomyelitis in adults is rare and generally linked
to immunodeficiency, diabetes, vasculopathy, precedent
trauma or surgery [4]. A haematogenous spread of bac-
teria leading to osteomyelitis is mostly seen in prepubes-
cent children or elderly patients and is characterised by
Figure 1 Radiograph of the right humerus: cortical
disaggregation suggesting a permeative process which can be
seen at the lateral, diaphyseal corticalis (arrows).
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nidation of bacteria within bones without direct trauma
or open wound [4]. Haematogenous osteomyelitis is well
known as being the most common musculoskeletal com-
plication in patients with HIV or AIDS [5]. However, in
the literature there is not one single case of acute, haema-
togenous pneumococcal osteomyelitis affecting long bones
in an otherwise healthy adult patient who lacks trauma
history or immunodeficiency.
Bacteria causing haematogenous osteomyelitis reflect
their frequency in the blood as a function of age [6,7].
Thus, organisms most commonly encountered in infants
and neonates include Staphylococcus aureus, group B
streptococci, coagulase-negative staphylococci and dif-
ferent other streptococci [7-10]. With age, S. aureus
dominates. In elderly people, commonly subject to
gram-negative bacteremia, osteomyelitis - especially
vertebral osteomyelitis - can also be caused by this
group of microorganisms [11]. Pneumococci as uncom-
mon infectious agent of the bone are rarely known to
cause vertebral osteomyelitis [4,12-14]. Pneumococcal
bone manifestations are generally linked to clinically
apparent upper and lower respiratory tract infections
caused by S. pneumoniae, sickle cell anemia [4] or direct
bone trauma [12,13]. Asplenia is also associated with an
increased risk of severe pneumococcal infections, thus
predisposing for affecting the bone via haematogenous
spread [15]. All mentioned co-factors were missing in
this particular case.
The clinical features of haematogenous, acute osteo-
myelitis in long bones are typical: chills, fever, and mal-
aise reflect the bacteremic spread of microorganisms as
shown by positive blood cultures. Strong pain and local
swelling are hallmarks of the local infectious process.
The clinical examination should include a search for
bone tenderness on palpitation [4]. By contrast, in our
case the clinical symptoms were a painless swelling and
nerve disfunction, being strongly suggestive for a con-
tinuously growing process commonly found in primary
bone tumours or metastases.
Figure 2 MRT of the right humerus: T1 with Gadolinium
(*tse2d1rs3), coronar views. a: Cortical infiltration of the middle
third of the diaphysis. The marrow is replaced by extensive edema,
only few hyperintense nodules are left. b: Extraosseal soft tissue
reaction (white arrow) affecting the radial nerve (blue arrow).The
differential diagnoses are: acute osteomyelitis, Ewing sarcoma or
osteosarcoma. Figure 3 Radiograph of the right humerus, anterioposterior
direction, postoperative status: drainage inserted via osseal
window.
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Distinguishing between subclinical haematogenous
osteomyelitis and primary or metastatic bone tumours
by imaging can be challenging [16,17]. The earliest
radiographic changes in osteomyelitis are swelling of soft
tissue, periosteal thickening or focal osteopenia, which is
frequently observed in malignant bone tumours as well
[17,18]. The typical appearance of acute osteomyelitis
in MRI is a localized area of abnormal marrow with
decreased signal intensity in T1-weighted images and
increased signal intensity in T2-weighted images [16], as
shown in our case. MRI is highly sensitive in the detec-
tion of pathologic changes in bone marrow and can give
precise information about the localization and extent of
an infection, but it has not yet provided pathognomonic
findings for osteomyelitis [17]. Thus, the presence of a
primary or metastatic bone tumour had to be excluded
by open biopsy.
Recommendations concerning antibiotic treatment of
hematogenous osteomyelitis differ regionally according
to the local type and resistance-pattern of the causing
bacteria. In Germany, the Paul-Ehrlich society would
favour a combination of 2nd generation cephalosporin
with clindamycin as first-line calculated therapy in
adults, assuming that the infection is most likely be
caused by S. aureus or β-haemolysing streptococci [19].
In pediatric osteomyelitis, up to 5% of all cases were iden-
tified to be caused by S. pneumoniae [20]. S. aureus as the
top-isolate and also pneumococci do respond to a first line
antibiotic treatment with a 1st generation cephalosporin,
clindamycin or high-dose penicillin G according to most
authors [20-22]. Notably, S. pneumoniae has been shown
to have a lower minimal inhibitory concentration (MIC)
to penicillin than other streptococci (e.g. S. pyogenes),
though the clinical impact is questionable and depends on
the breakpoint used. Altogether, resistant strains are not
frequent and account for only 0.24% [23]. Unlike in adult
osteomyelitis, no extensive surgical therapy is required in
children. However, it is also important to gain representa-
tive tissue samples from the bone to be able to initiate
targeted therapy after culture [18]. The duration of the
antibiotic treatment should be 1–3 months. Recent studies
challenged this approach and suggest that 20 days of treat-
ment including an initial i.v. period of 2–4 days should be
sufficient to control the infection [22].
Invasive pneumococcal infections in adults are rare
and generally affect immunodeficient patients. Resistance-
patterns to antibiotics vary regionally and depend on the
breakpoint of the MIC-definition used. In most countries
high-dose parenteral penicillin G or cefuroxim are recom-
mended as first-line therapy. Cefriaxone has been shown
to have one of the lowest MICs making this substance ef-
fective, especially in the treatment of severe pneumococcal
infections [24,25]. Specific treatment recommendations
for pneumococcal osteomyelitis in adults are completely
missing. On the basis that ceftriaxone is a very effective
substance against other severe pneumococcal infections in
pediatric and aduld patients [2,25] we adopted this sub-
stance once the bacteria was identified and were able to
control the symptoms within a short period. Retrospect-
ively, one can assume that high-dose penicillin G would
have had the same efficacy. In addition, the continuation of
cefuroxime, probably combined with clindamycin would
have been another reasonable alternative.
According to recent treatment guidelines, the initial
i.v. therapy of hematogenous osteomyelitis should last
for 1–4 weeks and should be continued by p.o. therapy
for 2–6 weeks [19]. Since our patient received i.v. ther-
apy for only 10 days, the total duration of therapy was
rather short. However, since all inflammatory parameters
were within the normal range and clinical inspection did
also not reveal symptoms of infection 30 days after dis-
charge, we stopped therapy at this time point. As given
above, therapy for uncomplicated cases of osteomyelitis in
children is even shorter [26,27]. 2nd and 3rd generation
cephalosporins were identified as major risk factors for
developing pseudomembranotic colitis, especially in com-
bination with clindamycin [28,29]. We therefore decided
to use the 2nd generation cephalosporin alone for ambula-
tory treatment.
Conclusions
Haematogenous spreading of bacteria can cause acute
osteomyelitis in prepubescent children and immunode-
ficient adults. Frequently, the vertebral bodies are affected.
Manifestations in long bones seem to be exceptional in
immunocompetent patients but should be considered. S.
pneumoniae is an unexpected bacterial agent in mature
patients showing absence of respiratory tract infections or
pharyngeal colonisation. Non-specific clinical and imaging
findings necessitate open biopsy. Microbiological and
pathologic evaluation of the material obtained should be
performed to isolate the causative pathogen and achieve
appropriate treatment.
To summarize, not one of the mentioned etiological
aspects for developing acute, haematogenous osteomye-
litis matches the case described and the clinical symptoms
were misleading. Nevertheless, close workup of clinical
and radiological findings led to the suspicion of acute
osteomyelitis, which was confirmed and completed by the
microbiological results. Therefore, this case approves the
surgical principle: “Biopsy what you culture and culture
what you biopsy!”
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